Webinar: ACR/CHEST ILD Guidelines in Practice| Video: All the Lonely People

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

Guidance

Subcategories:Clinical Criteria/GuidelinesEthicsLegal UpdatesLegislation & AdvocacyMeeting ReportsResearch Rheum

Figure 2: High-resolution computed tomography showed evidence of interstitial lung disease.

High-resolution computed tomography shows evidence of ILD.

The ACR/CHEST ILD Guidelines in Practice, a video
In collaboration with the American College of Chest Physicians, the ACR released two new comprehensive guidelines aimed at improving the screening, monitoring, and treatment of patients with interstitial lung disease (ILD) secondary to systemic autoimmune rheumatic diseases (SARDs). Recently, Sindhu R. Johnson, MD, PhD, professor of medicine at the University of Toronto, Canada, director of the Toronto Scleroderma Program and principal investigator for the guideline, and Elana J. Bernstein, MD, MSc, Florence Irving associate professor of medicine in the Division of Rheumatology at Columbia University, New York City, and co-first author, presented a webinar to talk about how the guidelines were developed and present some of the recommendations and their rationale: Watch the recording now!

 

Reading Rhuem

Robyn T. Domsic, MD; Gail C. Davis, RN, EdD; Mary Corr,MD  |  

Handpicked Reviews of Contemporary Literature

Audioconference: Management of Fibromyalgia

  |  

Tremendous progress is being made in the area of fibromyalgia,” says Dan Clauw, MD, professor of medicine in the division of rheumatology at the University of Michigan in Ann Arbor and moderator of the March 14 audioconference on the current management of fibromyalgia. “However,” he continues, “as in many fields of medicine, those who are not directly involved in fibromyalgia research and treatment are not aware of the progress that has been made.”

Legislative Priorities in 2007

  |  

In 2007, the ACR Government Affairs Committee will focus on correcting the Medicare reimbursement formula, countering increased cuts to diagnostic imaging, and the enactment of the Arthritis Prevention, Control, and Cure Act. Increasing advocacy among ACR members will also be a top priority.

The Chimeric Self

J. Lee Nelson, MD, and Anne Stevens, MD, PhD  |  

Michrochimerism research offers insights into several autoimmune conditions

ARHP Positioned for Continued Success in 2007

Karen L. Kerr, MSN, NP, CPNP, APRN-BC  |  

The ARHP is committed to advancing the knowledge and skills of health professionals in the area of rheumatology in order to improve health outcomes for people with or at risk for rheumatic disease and musculoskeletal conditions. In 2005, the ARHP Executive Committee developed a three-year, long-range plan, which identified the following priorities for our organization…

ACR Legislative Reception

  |  

The ACR Government Affairs Committee and ARHP Advocacy Subcommittee met in Washington, DC, on September 26 to discuss current legislative priorities and to participate in their annual legislative reception on Capitol Hill. Committee members and staff exchanged ideas on ways to increase advocacy and political involvement from ACR/ ARHP members. Increasing advocacy is a primary focus for the Government Affairs Committee (GAC) and Advocacy Subcommittee because it is essential that Congress be aware of the magnitude of our concerns.